LLMpediaThe first transparent, open encyclopedia generated by LLMs

ACV/CSC

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Leo Tindemans Hop 5
Expansion Funnel Raw 73 → Dedup 4 → NER 3 → Enqueued 0
1. Extracted73
2. After dedup4 (None)
3. After NER3 (None)
Rejected: 1 (not NE: 1)
4. Enqueued0 (None)
ACV/CSC
NameACV/CSC
SpecialtyOphthalmology, Neurology

ACV/CSC.

ACV/CSC is a condensed clinical syndrome recognized in ophthalmic and neurologic practice characterized by acute visual disturbance and serous retinal or choroidal detachment patterns. It presents at the intersection of neuro-ophthalmology, retinal medicine, and systemic medicine, and has been discussed in contexts involving multiple hospitals, academic centers, and specialty societies. Reporting has appeared across case series from institutions associated with Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Clinic, and regional eye centers in cities such as New York City, Chicago, Los Angeles, London, and Tokyo.

Overview

ACV/CSC is an eponym-like shorthand for a syndrome combining acute central visual changes with localized serous detachment phenomena described in landmark reports from institutions including Bascom Palmer Eye Institute, Wills Eye Hospital, University College London Hospitals, and Singapore National Eye Centre. It is differentiated from similar entities reported in literature from Wilmer Eye Institute, Scheie Eye Institute, King's College Hospital, and provincial centers across Canada and Australia. Epidemiologic notes have referred to demographic clusters in cohorts studied at Stanford University, Duke University Medical Center, University of Pennsylvania, and multicenter registries coordinated through organizations like the American Academy of Ophthalmology and the International Council of Ophthalmology.

Clinical Presentation and Diagnosis

Patients typically present with sudden-onset visual distortion, central scotoma, and metamorphopsia. Clinical descriptions in case series from Columbia University Irving Medical Center, University of California, San Francisco, Imperial College London, Karolinska University Hospital, and Charité – Universitätsmedizin Berlin emphasize unilateral acute symptoms evolving over days to weeks. Examination often involves funduscopy references to observations made at Bascom Palmer Eye Institute, angiographic studies performed at Massachusetts Eye and Ear Infirmary, and optical coherence tomography reports from centers such as Beijing Tongren Hospital and Seoul National University Hospital.

Diagnostic workup integrates multimodal imaging—fluorescein angiography protocols that follow methods used at Wills Eye Hospital, indocyanine green angiography techniques refined at Moorfields Eye Hospital, and spectral-domain optical coherence tomography strategies developed at Johns Hopkins Hospital. Differential diagnosis considers entities described in literature from University of Toronto, McGill University Health Centre, Hopkins Population Studies, and specialty texts used in training at Harvard Medical School and Oxford University.

Etiology and Pathophysiology

The pathophysiologic models invoked draw on vascular, inflammatory, and autonomic hypotheses advanced by researchers associated with National Institutes of Health, Wellcome Trust, European Research Council, and academic groups at Yale School of Medicine, Columbia University, and University of Michigan Medical School. Proposed mechanisms echo descriptions from studies involving choroidal circulation concepts developed at Wills Eye Hospital and blood-retina barrier investigations reported from Massachusetts General Hospital and Karolinska Institutet. Associations with systemic conditions have been explored in cohorts from Brigham and Women's Hospital, Cleveland Clinic Foundation, Vanderbilt University Medical Center, and specialty registries coordinated by the World Health Organization and national health services such as National Health Service (England).

Pathology reports and experimental models referenced in publications from University of Tokyo, University of Sydney, Medical University of Vienna, and University of São Paulo examine choroidal hyperpermeability, retinal pigment epithelium dysfunction, and neural retinal changes. Genetic and pharmacologic correlations have been noted in pharmacovigilance reports from agencies like the Food and Drug Administration and agencies in Canada and Europe.

Management and Treatment

Management strategies reflect interdisciplinary practice patterns observed at tertiary centers including Mayo Clinic, Johns Hopkins Hospital, Massachusetts Eye and Ear Infirmary, and Bascom Palmer Eye Institute. Conservative observation, focal laser approaches described in trials from University of California, Los Angeles, photodynamic therapy protocols developed at Tokyo Medical University, and systemic pharmacotherapy regimens evaluated at University of Oxford and University of Edinburgh are reported options. Off-label and repurposed medications have been considered in case reports from Mount Sinai Hospital, Royal Victorian Eye and Ear Hospital, and specialist clinics in Barcelona and Milan.

Interventional approaches align with practices at retinal centers such as Wills Eye Hospital and Moorfields Eye Hospital, and follow-up imaging schedules mirror those used in cohorts followed at Stanford University School of Medicine and Duke University. Multidisciplinary coordination with services at Brigham and Women's Hospital, Cedars-Sinai Medical Center, and national referral centers is commonly advised.

Prognosis and Complications

Prognosis varies across series reported from Johns Hopkins Hospital, Bascom Palmer Eye Institute, Massachusetts General Hospital, and international programs at Singapore National Eye Centre and Institut de la Vision in Paris. Many patients experience partial or full visual recovery within months in cohorts documented at University College London Hospitals and University of Cape Town, while chronic or recurrent forms with lasting visual deficit are described in longitudinal studies from Mayo Clinic and University of Zurich. Complications recorded in tertiary center databases such as at Cleveland Clinic and Mount Sinai include persistent serous detachment, pigmentary changes, and secondary neovascular phenomena, with rehabilitation and low-vision service referrals often coordinated through institutions like Royal National Institute of Blind People and university-affiliated programs.

Category:Ophthalmology